EGALET CORPORATION, as Issuer, the Guarantors party hereto as of the date hereof and any Guarantor that becomes party hereto pursuant to Section 4.10 hereof 13% Senior Secured NotesIndenture • September 1st, 2016 • Egalet Corp • Pharmaceutical preparations • New York
INDENTURE dated as of August 31, 2016 among Egalet Corporation, a Delaware corporation with an address at 600 Lee Road, Suite 100, Wayne, Pennsylvania 19087 (the “Issuer”), the Guarantors party hereto as of the date hereof, any other Guarantor that becomes party hereto pursuant to Section 4.10, and U.S. Bank National Association, as trustee (as more fully defined in Section 1.01, the “Trustee”) and as collateral agent (as more fully defined in Section 1.01, the “Collateral Agent”).
COLLATERAL AGREEMENT DATED AS OF AUGUST 31, 2016 AMONGCollateral Agreement • September 1st, 2016 • Egalet Corp • Pharmaceutical preparations • New York
THIS COLLATERAL AGREEMENT (as amended, extended, renewed, restated, supplemented, waived or otherwise modified from time to time, this “Agreement”) is entered into as of August 31, 2016, by and among EGALET CORPORATION, a Delaware corporation with an address at 600 Lee Road, Suite 100, Wayne, Pennsylvania 19087 (the “Issuer”), EGALET US INC., a Delaware corporation (“Egalet US”), EGALET LIMITED, a private limited company formed under the law of England and Wales (“Egalet UK”), the other SUBSIDIARY PARTIES (as defined below) from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, in its capacity as Trustee (and its successors under the Indenture (as defined below), in such capacity, the “Trustee”), and U.S. BANK NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the “Collateral Agent”).
PURCHASE AGREEMENT dated August 31, 2016 among EGALET CORPORATION, THE SUBSIDIARY GUARANTORS NAMED HEREIN and THE PURCHASER NAMED HEREIN $80,000,000 13% SENIOR SECURED NOTESPurchase Agreement • September 1st, 2016 • Egalet Corp • Pharmaceutical preparations • New York
Egalet Corporation, a Delaware corporation (the “Issuer”), and the Subsidiaries of the Issuer named on the signature pages hereto (the “Subsidiary Guarantors”), hereby covenant and agree with you as follows:
ROYALTY RIGHT AGREEMENT {FOR USE ONLY IN FIRST CLOSING DATE AGREEMENT: dated as of AUGUST 31, 2016} {FOR USE ONLY IN SECOND CLOSING DATE AGREEMENT: dated as of , 201 } between EGALET CORPORATION and THE PURCHASER NAMED HEREINRoyalty Right Agreement • September 1st, 2016 • Egalet Corp • Pharmaceutical preparations • New York
